CARLSBAD, Calif., March 28,
2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced its participation in fireside chats
at the following investor conferences:
- Guggenheim Virtual Genomic Medicines and Rare Disease Days on
Tuesday, April 4, 2023
- 22nd Annual Needham Virtual Healthcare Conference on
Monday, April 17, 2023
A live webcast of the presentations can be accessed on the
Investors & Media section of the Ionis website at
www.ionispharma.com. The replay will be available on the Ionis
website within 48 hours and will be archived for a limited
time.
About Ionis
Pharmaceuticals
For more than 30 years, Ionis has been a leader in RNA-targeted
therapy, pioneering new markets and changing standards of care with
its novel antisense technology. Ionis currently has three marketed
medicines and a promising late-stage pipeline highlighted by
cardiovascular and neurological franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision to become the leader in
genetic medicine, utilizing a multi-platform approach to discover,
develop and deliver life-transforming therapies.
To learn more about Ionis, visit www.ionispharma.com and follow
us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301782684.html
SOURCE Ionis Pharmaceuticals, Inc.